Kane Biotech Announces Adoption of Amended and Restated Stock Option Plan and Performance and Restricted Share Unit Plan
June 30, 2022 16:05 ET
|
Kane Biotech Inc.
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, June 30, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane...
Kane Biotech Announces Amended Credit Facility
June 15, 2022 08:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, June 15, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF), (the “Company” or “Kane Biotech”), today announces that it has further amended its credit agreement...
Kane Biotech Announces First Quarter 2022 Financial Results
May 26, 2022 16:05 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, May 26, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Biotech to Release First Quarter 2022 Financial Results on May 26 – Conference Call to Follow
May 19, 2022 08:30 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, May 19, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Biotech Obtains ISO 13485 Certification
May 18, 2022 08:30 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, May 18, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), announced today that it has obtained ISO 13485:2016 certification...
Kane Biotech Announces Closing of Private Placement
May 17, 2022 07:00 ET
|
Kane Biotech Inc.
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, May 17, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company” or...
Kane Biotech Announces Update on Private Placement
May 06, 2022 08:30 ET
|
Kane Biotech Inc.
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, May 06, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (“Kane...
Kane Biotech Announces Extension of Private Placement Offering
April 29, 2022 16:05 ET
|
Kane Biotech Inc.
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, April 29, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane...
STEM Animal Health Awarded Veterinary Oral Health Council (VOHC) Seal of Acceptance for Pet Oral Care Water Additive
April 07, 2022 12:40 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, April 07, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), is pleased to announce today that STEM Animal Health Inc....
Kane Biotech Appoints Dr. Gregory Schultz as Chief Scientific Officer
April 05, 2022 08:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, April 05, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), announced today the appointment of Gregory Schultz, PhD, a world...